App-Quantinova.ai

Service evaluation of endocrine and surgical outcomes post-pituitary surgery for non-functioning pituitary macroadenomas (NFPAs) in a subset of patients

Rosemary Ikegwu - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pituitary adenomas

hGH

Pituitary Coma? Discordant pituitary biochemistry after consumption of a commercially available ‘Sleep Activator’.

Benjamin Phillips - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Hypothyroidism

Hydrocortisone

Age and puberty based IGF-1 normative data in healthy children from North India.

Bhanu Malhotra - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Isolated short stature

Mecasermin

Pituitary Hyperplasia secondary to Severe Primary Hypothyroidism

Harriet Esdaile - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Transient Ischemic Attack

Levothyroxine

Vanishing Pituitary tumour in a postpartum patient - a diagnostic dilemma

Noha Meneissy - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Hydrocortisone

Clinical & Epidemiological characteristics of patients undergoing pituitary-related surgeries in a tertiary care centre in Sri Lanka

Piyumi Wijewickrama - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Fluid and sodium disorders in patients undergoing pituitary related surgeries in a tertiary care centre in Sri Lanka, with associations and risk factors; a prospective, observational study

Piyumi Wijewickrama - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

Head and neck paragangliomas: the belfast trust experience

Milad Darrat - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Paraganglioma

stannous fluoride

‘The efficiency of the treatment by Sandostatin-Lar in patients with non-functional pituitary macroadenomas’

Malika Mirtukhtaeva - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pituitary adenomas

Octreotide acetate

The natural course of hypopituitarism at diagnosis and following therapy in non-functioning pituitary macroadenomas

Ziad Hussein - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Pituitary adenomas

N/A

Endocrinopathy behind the facemask

Sandhi Nyunt - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

hGH

Management of SIADH in patients with acute admissions to hospital: a single centre experience

Vinit Shah - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Syndrome of inappropriate secretion of antidiuretic hormone

Sochlor

Cushing syndrome and disease: A doctor of philosophy study conducted by a patient

Margaret McBride - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Cushing's syndrome

N/A

Investigating the prevalence of hypogonadism and associated cardiovascular risk of males presenting with infertility: Results from a diverse and multi-ethnic UK patient cohort

Vina Soran - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Infertility

N/A

Perceptions and experiences of women with polycystic ovary syndrome- a systematic review

Gar Mun Lau - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Polycystic Ovary Syndrome

N/A

Effect of testosterone on body composition - randomised placebo-controlled study in hypogonadal men with uncontrolled type-2 diabetes - STRIDE STRUDY

Preethi Mohan Rao - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 2 diabetes mellitus

LPCN 1111

Combined omic analysis revealed autism-linked NLGN3as new candidate gene associated to GnRH neuron development and disease

Roberto Oleari - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypogonadotropic hypogonadism

Tamsulosin Hydrochloride

Have we ignored red cell parameters in Turner Syndrome? Results from a single specialist centre

Katharina Beck - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Turner syndrome

hGH

Daytime salivary androgen rhythm by LC-MS/MS in women affected by Polycystic Ovary Syndrome (PCOS) fulfilling the three Rotterdam diagnostic criteria

Flaminia Fanelli - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Polycystic Ovary Syndrome

prasterone

PCOS SEVa: High prevalence anxiety and body dysmorphia in women with PCOS attending specialist care in the UK and India

Meghnaa Hebbar - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Body Dysmorphic Disorder

N/A

Filters

45280 Abstracts